Serum levels of cefotaxime and desacetyl-cefotaxime were studied in 18 patients with hepatic cirrhosis after an intravenous bolus injection of 2 g of cefotaxime. Blood levels were independent of the degree of hepatic dysfunction and did not differ from those reported in normal individuals.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/jac/14.suppl_b.143 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!